Hiroya Kondo (Aki Yoshida)

Years Active: 2021-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Toshiyuki Takemori, Teruya Kawamoto, Hitomi Hara, Naomasa Fukase, Shuichi Fujiwara, Ikuo Fujita, Takuya Fujimoto, Masayuki Morishita, Kazumichi Kitayama, Shunsuke Yahiro, Tomohiro Miyamoto, Masanori Saito, Jun Sugaya, Katsuhiro Hayashi, Hiroyuki Kawashima, Tomoaki Torigoe, Tomoki Nakamura, Hiroya Kondo, Toru Wakamatsu, Munenori Watanuki, Munehisa Kito, Satoshi Tsukushi, Akihito Nagano, Hidetatsu Outani, Shunichi Toki, Shunji Nishimura, Hiroshi Kobayashi, Itsuo Watanabe, Yusuke Demizu, Ryohei Sasaki, Takumi Fukumoto, Takahiro Niikura, Ryosuke Kuroda, Toshihiro Akisue
Clinical Outcome of Patients with Pelvic and Retroperitoneal Bone and Soft Tissue Sarcoma: A Retrospective Multicenter Study in Japan. Cancers 14 (12) (2022)
Kazuhisa Sugiu, Hiroshi Tazawa, Joe Hasei, Yasuaki Yamakawa, Toshinori Omori, Tadashi Komatsubara, Yusuke Mochizuki, Hiroya Kondo, Shuhei Osaki, Tomohiro Fujiwara, Aki Yoshida, Toshiyuki Kunisada, Koji Ueda, Yasuo Urata, Shunsuke Kagawa, Toshifumi Ozaki, Toshiyoshi Fujiwara
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. Cancer chemotherapy and pharmacology 88 (3) (2021)
Tomohiro Fujiwara, John Healey, Koichi Ogura, Hiroya Kondo, Hiroya Kondo, Toshiaki Hata, Hiroshi Tazawa, Hiroshi Tazawa, Toshiyuki Kunisada, Toshiyoshi Fujiwara, Toshiyoshi Fujiwara, Toshifumi Ozaki
Role of Tumor-Associated Macrophages in Sarcomas. Cancers 13 (5) (2021)

Hiroya Kondo.css-eqlu8i{font-size:small;padding-left:4px;} (Aki Yoshida)